Slate Medicines, a biotech firm focused on migraine treatments, has appointed Mark W. Hahn to its Board of Directors. Hahn brings over 25 years of experience in life sciences, including leading companies through financial milestones and FDA approvals. His expertise will support Slate's efforts to advance its lead migraine drug candidate, SLTE-1009, aimed at preventing migraines. This move strengthens the company's leadership as it seeks to deliver new therapies for underserved migraine patients.
The Office of the Comptroller of the Currency (OCC) has given preliminary conditional approval for World Liberty Trust Company to become a national trust bank, allowing it to issue and manage its USD1 stablecoin under federal regulation. This marks a...
World Liberty Financial, backed by the Trump family, received preliminary approval for a national bank trust charter from the Office of the Comptroller of the Currency. This approval allows the company to manage its USD1 stablecoin under federal regu...
Zcash (ZEC) surged to $795.03, surpassing its 12-month high by 8.5%, driven by a strong uptrend confirmed by high trading volume of $2.53 billion, well above its 30-day average. The coin's market cap reached $13.38 billion, ranking it 11th among cryp...
Ethereum's price jumped 31% in a week, driven mainly by a massive 1,514% increase in short liquidations averaging $131 million weekly. This forced short covering boosted trading volumes and pushed network activity higher, with base fees up 189% and f...
Cryptocurrency markets rallied strongly this week, with Bitcoin climbing over 20% to nearly $80,000, driven by ETF inflows, improved liquidity, and a risk-on sentiment. Altcoins also performed well, especially Ethena (ENA) which surged over 100%, and...
